Emerging evidence also suggests that ClC-5 and OCRL may be expressed in human podocytes, potentially explaining the development of focal segmental glomerulosclerosis (FSGS) lesions observed in kidney biopsies of patients with DD1 and DD2 [25, 26]. The gene discussed is CLCN5; the disease is focal segmental glomerulosclerosis.